3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Rhabdomyosarcoma
1
Recurrence
1
Recurent Vulvar Carcinoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Lymphoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
HIV Infections
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Eyelid Sebaceous Gland Carcinoma
1
Cervical Adenocarcinoma
1
Carcinoma, Ductal
1
Anus Neoplasms
1
Interventions
pembrolizumab
45
Paclitaxel
42
Carboplatin
34
Bevacizumab
18
Specimen Handling
17
Letrozole
16
lenvatinib
13
Magnetic Resonance Spectroscopy
12
dostarlimab
11
Cisplatin
11
Biopsy
11
Taxes
10
olaparib
9
Fulvestrant
9
Doxorubicin
9
abemaciclib
8
Megestrol Acetate
8
Docetaxel
8
durvalumab
7
atezolizumab
7
Nivolumab
7
Gemcitabine
7
Blood Specimen Collection
7
palbociclib
6
Oxaliplatin
6
Observation
6
Fluorouracil
6
niraparib
5
Surveys and Questionnaires
5
Progestins
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Sentinel Lymph Node Biopsy
×
1 year
×
Clear all
No trials found.